Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.

Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine. Cancer Treat Rep. 1978 Apr; 62(4):567-9.

View in: PubMed

subject areas

Adenocarcinoma
Adult
Aged
Altretamine
Bleomycin
Carcinoma, Small Cell
Carcinoma, Squamous Cell
Clinical Trials as Topic
Cyclophosphamide
Doxorubicin
Drug Resistance
Female
Humans
Lomustine
Lung Neoplasms
Male
Methotrexate
Middle Aged
Nitrosourea Compounds
Procarbazine
Triazines

authors with profiles

Harvey M. Golomb